國立虎尾科技大學 |

Agammaglobulinemia

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Agammaglobulinemia/ edited by Alessandro Plebani, Vassilios Lougaris.
other author:	Plebani, Alessandro.
Description:	IX, 119 p. 22 illus., 18 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Immunology. -
Online resource:	https://doi.org/10.1007/978-3-319-22714-6
ISBN:	9783319227146

Agammaglobulinemia
Agammaglobulinemia[electronic resource] /edited by Alessandro Plebani, Vassilios Lougaris. - 1st ed. 2015. - IX, 119 p. 22 illus., 18 illus. in color.online resource. - Rare Diseases of the Immune System,42282-6505 ;. - Rare Diseases of the Immune System,4.

Early B Cell Biology -- Agammaglobulinemia: Basic Pathogenesis and Clinical Spectrum (Including X-Linked and Autosomal Recessive Forms) -- Pulmonary Complications in Agammaglobulinemia -- Immunoglobulin Replacement Therapy: Past, Present, Future -- Mutational Spectrum of BTK: A Comprehensive Description -- Novel Therapeutic Options for X-Linked Agammaglobulinemia -- BTK in Non B Cells.

This book provides an updated overview of agammaglobulinemia, a rare form of primary immunodeficiency which is considered the prototype of the congenital humoral defects, and which is characterized by the absence of peripheral B cells and very low serum immunoglobulin levels. The book opens by discussing the highly orchestrated early B cell development in the bone marrow and the genes involved based on both human and animal models. The pathogenesis and clinical presentation of X-linked agammaglobulinemia, caused by mutations in the BTK (Bruton’s tyrosine kinase) gene, are then presented in detail, followed by descriptions of the clinical manifestations and molecular basis of the less frequent autosomal recessive and autosomal dominant forms of agammaglobulinemia. Patients’ management in terms of respiratory complications, gammaglobulin replacement therapy and the potential value of novel experimental therapeutic strategies are discussed. The book’s closing chapters offer a comprehensive and updated description of mutations in the BTK gene, and the expression and function of BTK in cells other than B cells.

ISBN: 9783319227146

Standard No.: 10.1007/978-3-319-22714-6doiSubjects--Topical Terms:

592892
Immunology.

LC Class. No.: QR180-189.5

Dewey Class. No.: 616.079

Agammaglobulinemia
LDR:02914nam a22004095i 4500 001 962303
003 DE-He213
005 20200629164121.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319227146 $9 978-3-319-22714-6
024 7 $a 10.1007/978-3-319-22714-6 $2 doi
035 $a 978-3-319-22714-6
050 4 $a QR180-189.5
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
072 7 $a MJCM $2 thema
082 0 4 $a 616.079 $2 23
245 1 0 $a Agammaglobulinemia $h [electronic resource] / $c edited by Alessandro Plebani, Vassilios Lougaris.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a IX, 119 p. 22 illus., 18 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Rare Diseases of the Immune System, $x 2282-6505 ; $v 4
505 0 $a Early B Cell Biology -- Agammaglobulinemia: Basic Pathogenesis and Clinical Spectrum (Including X-Linked and Autosomal Recessive Forms) -- Pulmonary Complications in Agammaglobulinemia -- Immunoglobulin Replacement Therapy: Past, Present, Future -- Mutational Spectrum of BTK: A Comprehensive Description -- Novel Therapeutic Options for X-Linked Agammaglobulinemia -- BTK in Non B Cells.
520 $a This book provides an updated overview of agammaglobulinemia, a rare form of primary immunodeficiency which is considered the prototype of the congenital humoral defects, and which is characterized by the absence of peripheral B cells and very low serum immunoglobulin levels. The book opens by discussing the highly orchestrated early B cell development in the bone marrow and the genes involved based on both human and animal models. The pathogenesis and clinical presentation of X-linked agammaglobulinemia, caused by mutations in the BTK (Bruton’s tyrosine kinase) gene, are then presented in detail, followed by descriptions of the clinical manifestations and molecular basis of the less frequent autosomal recessive and autosomal dominant forms of agammaglobulinemia. Patients’ management in terms of respiratory complications, gammaglobulin replacement therapy and the potential value of novel experimental therapeutic strategies are discussed. The book’s closing chapters offer a comprehensive and updated description of mutations in the BTK gene, and the expression and function of BTK in cells other than B cells.
650 0 $a Immunology. $3 592892
650 0 $a Rheumatology. $3 668542
650 0 $a Hematology. $3 645254
650 0 $a Pediatrics. $3 644839
650 0 $a Cell biology. $3 1253486
650 2 4 $a Cell Biology. $3 593889
700 1 $a Plebani, Alessandro. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1070092
700 1 $a Lougaris, Vassilios. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1070093
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319227139
776 0 8 $i Printed edition: $z 9783319227153
776 0 8 $i Printed edition: $z 9783319372495
830 0 $a Rare Diseases of the Immune System, $x 2282-6505 ; $v 4 $3 1257161
856 4 0 $u https://doi.org/10.1007/978-3-319-22714-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)